Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Epilepsy Seizure Detection With Innovative Tripolar EEG (tEEG)

NCT05944692 · tracked via the Priya Life Science USA tracker
Sponsor
CREmedical
Phase
Observational
Started
2025-09-01
Last updated
2026-10-27

Condition(s) studied

Epilepsy

Investigational drug(s) / intervention(s)

Tripolar electroencephalography

Tripolar electroencephalography: We will record physiological signals with the tripolar electroencephalography

Study summary

Concurrent electroencephalography (EEG) and new tripolar EEG (tEEG) will be recorded from adult and pediatric patients. In some patients stereo EEG (sEEG) will also be recorded concurrently.

Eligibility

Sex
ALL
Min age
6 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Pediatric (BCH): Age ≥ 6 years and \< 18 years * Adult (BNI): Age ≥ 18 years * Able to provide written informed consent or have a legally authorized representative able to provide consent; pediatric patients to provide assent when appropriate * Scheduled for routine outpatient EEG for clinical diagnosis * Able to participate in a post-EEG telemedicine video visit * Clinical diagnosis of epilepsy with epileptiform discharges on prior routine EEG * Scheduled for inpatient video-EEG monitoring for clinical diagnosis * MRI of brain available for co-registration * Confirmed diagnosis of focal epilepsy by prior video-EEG monitoring interpreted by board-certified epileptologist or clinical neurophysiologist * Scheduled for inpatient video-EEG monitoring with intracranial stereo-EEG electrodes for epilepsy presurgical evaluation * MRI of brain available for co-registration Exclusion criteria * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the integrity of the data * Any clinical suspicion of prion disease * History of allergy or adverse reaction to EEG electrode paste or gel * Scalp lesions or infections * Severe intellectual disability or behavioral disorders with inability to cooperate with EEG application or recording

Primary outcome measure(s)

  • Technical and diagnostic accuracy — up to 10 days
    1. Establish the technical accuracy of tEEG (ability to record waveforms accurately and reproducibly in clinical conditions in comparison to conventional EEG). 2. Establish the diagnostic accuracy of tEEG compared to conventional EEG (combination of improved artifact reduction, better interrater agreement for interictal epileptiform activity, and earlier identification of ictal patterns), as determined by blinded expert EEG readers.

Trial sites (2)

FacilityCityRegionStatus
Barrow Neurological Institute Dignity Health dba St. Joseph's Hospital and Medical Center Phoenix Arizona Recruiting
Boston Children's Hospital Boston Massachusetts Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05944692 on ClinicalTrials.gov ↗ ← All trials in the USA